Citation: | LI Jing, LI Xiao-feng, YAN Ni, LIU Ling-jiao. Evaluation the screening value of obesity-related indices for non-alcoholic fatty liver disease[J]. Chinese Journal of General Practice, 2023, 21(2): 195-198. doi: 10.16766/j.cnki.issn.1674-4152.002843 |
[1] |
FERKY B, RIBAS A, BAUMGARTNER C, et al. Incompatibility of the circadian protein BMAL1 and HNF4α in hepatocellular carcinoma[J]. Nat Commun, 2018, 9(1): 4349. doi: 10.1038/s41467-018-06648-6
|
[2] |
KWASNICKA D, NTOUMANIS N, HUNT K, et al. A gender-sensitised weight-loss and healthy living program for men with overweight and obesity in Australian Football League settings (Aussie-FIT): a pilot randomised controlled trial[J]. PLoS Med, 2020, 17(8): e1003136. DOI: 10.1371/journal.pmed.1003136.
|
[3] |
POLYZOS S, KOUNTOURAS J, MANTZOROS C. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics[J]. Metabolism, 2019, 92: 82-97. doi: 10.1016/j.metabol.2018.11.014
|
[4] |
LEE S W, SON J Y, KIM J M, et al. Body fat distribution is more predictive of all-cause mortality than overall adiposity[J]. Diabetes Obes Metab, 2018, 20(1): 141-147. doi: 10.1111/dom.13050
|
[5] |
KAHN H. The lipid accumulation product is better than BMI for identifying diabetes: a population-based comparison[J]. Diabetes Care, 2006, 29(1): 151-153. doi: 10.2337/diacare.29.01.06.dc05-1805
|
[6] |
孙亮亮, 谢虹, 张艳芳, 等. 蚌埠市某地区成人脂质蓄积指数与糖尿病患病风险关系的研究[J]. 中华全科医学, 2019, 17(7): 1204-1208. doi: 10.16766/j.cnki.issn.1674-4152.000902
SUN L L, XIE H, ZHANG Y F, et al. Relationship between lipid accumulation product and the risk of diabetes in adults of a region of Bengbu[J]. Chinese Journal of General Practice, 2019, 17(7): 1204-1208. doi: 10.16766/j.cnki.issn.1674-4152.000902
|
[7] |
DATTA S, PACHECO E, LUGO R, et al. Evaluation of anthropometric indices and lipid parameters to predict metabolic syndrome among adults in Mexico[J]. Diabetes Metab Syndr Obes, 2021, 14: 691-701. doi: 10.2147/DMSO.S281894
|
[8] |
KYROU I, PANAGIOTAKOS D B, KOULI G M, et al. Lipid accumulation product in relation to 10-year cardiovascular disease incidence in Caucasian adults: the ATTICA study[J]. Atherosclerosis, 2018, 279: 10-16. doi: 10.1016/j.atherosclerosis.2018.10.015
|
[9] |
MASTROMAURO C, POLIDORI N, GIANNINI C. Metabolic dysfunction-associated fatty liver disease in obese youth with insulin resistance and type 2 diabetes[J]. Curr Opin Pediatr, 2022, 34(4): 414-422. doi: 10.1097/MOP.0000000000001138
|
[10] |
中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南(2010年修订版)[J]. 中华肝脏病杂志, 2010, 18(3): 163-166. https://www.cnki.com.cn/Article/CJFDTOTAL-YXQY201207005.htm
Fatty liver and alcoholic liver disease group, Chinese Association of Hepatology. Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition[J]. Chinese Journal of Hepatology, 2010, 18(3): 163-166. https://www.cnki.com.cn/Article/CJFDTOTAL-YXQY201207005.htm
|
[11] |
LI J, ZOU B, YEO Y H, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2019, 4(5): 389-398. doi: 10.1016/S2468-1253(19)30039-1
|
[12] |
DONINI L M, PINTO A, GIUSTI A M, et al. Obesity or BMI paradox? Beneath the tip of the iceberg[J]. Front Nutr, 2020, 7: 53. doi: 10.3389/fnut.2020.00053
|
[13] |
ZHOU W, SHAN N C, WEI J, et al. Cross-sectional and longitudinal associations between lipid accumulati on product and hyperuricemia[J]. Nutr Metab Cardiovasc Dis, 2022, 32(10): 2348-2355. doi: 10.1016/j.numecd.2022.06.022
|
[14] |
LIN I T, LEE M Y, WANG C W, et al. Gender differences in the relationships among metabolic syndrome and various obesity-related indices with nonalcoholic fatty liver disease in a Taiwanese population[J]. Int J Environ Res Public Health, 2021, 18(3): 857. doi: 10.3390/ijerph18030857
|
[15] |
ZHANG Y, LI B, LIU N, et al. Evaluation of different anthropometric indicators for screening for no nalcoholic fatty liver disease in elderly individuals[J]. Int J Endocrinol, 2021, 2021: 6678755. DOI: 10.1155/2021/6678755.
|
[16] |
PALMA R, PRONIO A, ROMEO M, et al. The role of insulin resistance in fueling NAFLD pathogenesis: from molecular mechanisms to clinical implications[J]. J Clin Med, 2022, 11(13): 3649. doi: 10.3390/jcm11133649
|
[17] |
COBOS P, RUIZ M, VILCHES A, et al. Metabolically healthy obesity: inflammatory biomarkers and adipokines in elderly population[J]. PLoS One, 2022, 17(6): e0265362. DOI: 10.1371/journal.pone.0265362.
|
[18] |
ANTRACO V, HIRATA B, CRUZ M, et al. Omega-3 polyunsaturated fatty acids prevent nonalcoholic steatohepatit is (NASH) and stimulate adipogenesis[J]. Nutrients, 2021, 13(2): 622. doi: 10.3390/nu13020622
|